Clinicians should take into consideration PHP-Ia in patients referred with short stature, and patients with an AHO phenotype must be further evaluated for hormone resistance, GNAS gene mutation, Gsα activity. The gene discussed is GNAS; the disease is pseudohypoparathyroidism type 1A.